Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5

Journal of Acquired Immune Deficiency Syndromes

Volumn 29, Issue 4, 2002, Pages 330-339

  Elbeik, Tarek ^a   Alvord, W Gregory ^a   Trichavaroj, Rapee ^a   De Souza, Mark ^a   Dewar, Robin ^a   Brown, Arthur ^a   Chernoff, David ^a   Michael, Nelson L ^a   Nassos, Patricia ^a   Hadley, Keith ^a   Ng, Valerie L ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

Amplicor; Branched DNA (bDNA); HIV 1 subtypes; Viral load

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTATION; ARTICLE; DIAGNOSTIC ACCURACY; GENBANK; HUMAN IMMUNODEFICIENCY VIRUS 1; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; VIRUS ISOLATION; VIRUS LOAD; VIRUS STRAIN;

EID: 0036534535     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200204010-00002     Document Type: Article

References (52)

1. Most HIV-1 genetic subtypes have entered Sweden
2. At least five HIV-1 sequence subtypes (A, B, C, D, A/E) occur in England
3. Increasing diversity of HIV-1M serotypes in French blood donors over a 10-year period (1985-1995)
4. Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia
5. High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland
6. Drug resistance patterns, genetic subtypes, clinical features, and risk factors in military personnel with HIV-1 seroconversion
7. Diverse HIV-1 genetic subtypes in UK
8. Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa
9. HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network
10. Large proportion of non-B HIV-1 subtypes and presence of zidovudine resistance mutations among German seroconvertors
11. Longstanding presence in Belgians of multiple non-B HIV-1 subtypes
12. Recombinant human immunodeficiency viruses type 1 circulating in Spain
13. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment
14. Presence of human immunodeficiency virus (HIV) type 1, group M, non-B subtypes, Bronx, New York: A sentinel site for monitoring HIV genetic diversity in the United States
15. Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China
16. Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple
17. Virtually full-length subtype F and F/D recombinant HIV-1 from Africa and South America
18. HIV-1 genetic diversity
19. Subtype G and multiple forms of A/G intersubtype recombinant human immunodeficiency virus type 1 in Nigeria
20. Infectious molecular clones with the nonhomologous dimer initiation sequences found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro
21. Dimerization of retroviral genomic RNAs: Structural and functional implications
22. Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants
23. Characterization of subtype A HIV-1 from Africa by full genome sequencing
24. Identification of non-B human immunodeficiency virus type 1 subtypes in rural Georgia
25. Clinical implications of identifying non-B subtypes of human immunodeficiency virus type 1 infection
26. Preventive HIV vaccine development in Thailand
27. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology
28. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma
29. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml
30. PCR detection of human immunodeficiency virus type 1 proviral DNA sequences
31. The effects of internal primer-template mismatches on RT-PCR: HIV-1 model studies
32. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type I and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes
33. Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1
34. Use of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 to assess the performance of viral RNA quantitation tests
35. Single rapid real-time monitored isothermal RNA amplification assay for quantification of human immunodeficiency virus type I isolates from groups M, N, and O
36. Seven human immunodeficiency virus (HIV) antigen-antibody combination assays: Evaluation of HIV seroconversion sensitivity and subtype detection
37. Comparative performance of three viral load assays on human immunodeficiency virus type I (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0
38. Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma
39. Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma
40. A procedure to test hypotheses for nonlinear models
41. Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples
42. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type I RNA viral load assays: Bayer bDNA Quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5
43. Quality of human immunodeficiency virus viral load testing in Australia
44. Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients
45. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes
46. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma